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Patients with obstructive jaundice have an increased incidence of peri-operative complications and
immune dysfunction. This study was to investigate interleukin (IL)-12 (a cellular immunity stimulant),
levels in jaundiced patients. 23 jaundiced patients and 17 controls were studied. There was significantly
increased monocyte IL-12 production in jaundice, as measured by an ELISA, compared with that in
controls (p<0.01 by Mann-Whitney U test). A similar increase is seen in both benign and malignant
jaundice. There was no difference between plasma IL-12 levels in the two groups. It is concluded that in
jaundice, monocytes have a significantly increased capacity to release IL-12. This suggests that IL-12 may
play a role in the immune dysfunction in jaundiced patients.
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INTRODUCTION
Patients with obstructive jaundice are associated with
an increased incidence ofperioperative complications,
such as renal failure, sepsis, haemorrhagic disorders
and endotoxaemia 1-5. For some years it has been
known that these patients have depressed Reticulo-
Endothelial system (RES) phagocytic functions 5-8. It
has been reported recently that the secretory functions
from monocyte and neutrophils, for example, super-
oxide production, cytokine secretions, and lysosomal
enzyme secretions are increased, and this may be re-
lated in some way to a patient’s clinical outcome 9-12.
In other studies, it has been shown that patients with
jaundice demonstrate lymphocyte activation as indi-
cated by increased IL-2 receptor levels 13.
Interleukin-12, otherwise known as natural killer
stimulatory factor (NKSF), is a recently defined
cytokine which has major effects on both lymphocytes
andNK cells. Both proliferation and function ofthese
two cell types are stimulated by IL-1214-9. The
monocyte/macrophage is a key cell type in immune
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regulation, it produces an array ofcytokines including
IL-1, IL-6, IL-8, TNF alpha. This cell is also a key
contributor to IL-12 in vivo 20. A markedly raised
production of IL-1, IL-6, and TNF from monocytes
has been shown to be related to patients’ poor progno-
sis in sepsis, trauma, and burn injuries 21-23.
In order to determine the monocyte cytokine pro-
duction and the possible relationship to cellular im-
munity, we have studied the monocyte production and
blood level of interleukin- 12.
PATIENTS, METHODS, AND RESULTS
23 patients with biliary obstructions (median age 71
years, 14 male, 9 female) were studied. Of these pa-
tients 14 had malignant diseases (cholangiocarcinoma
or pancreatic cancer) and the others gall stones or
benign biliary strictures. 17 controls were studied (10
had herniae or gall stones without jaundice, 7 colon
cancer without liver metastasis, median age 64 years).
Peripheral blood was taken before any clinical in-
tervention. The blood was processed at 4C. Plasma
was obtained by centrifugation at 2500rpm for 25
minutes. Monocytes were separated by a standard
Ficoll-Hypaque separation and purified by adherence
techniques. The monocyte population was assessed by
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a non-specific esterase stain (monocyte population
was over 90% after adherence). Cells were stimulated
in vitro with lipopolysaccharide (10t.tg/ml) for 24 hours
and cell free-supernatant were stored at-80C for
later assay.
IL-12 was measured using a specific ELISA with
monoclonal 20C2 as capture antibody and R7926
as detecting antibody (Kindly supplied by Genetic
Institute, Cambridge, USA). Secondary antibody was
horse-reddish peroxidase conjugated IgG (Biorad)
and the colour was developed using orthophenylene-
diamine (OPD) and absorbance measured at 492 nm
on a Tiertek Multiscanner. Recombinant human
interleukin-12 was used as standard.
There was a significantly increased IL-12 produc-
tion injaundice, 205.6+2.8pg/ml (mean+SEM), com-
pared with 182.2+4.2pg/ml in controls (p <0.01 by
Mann-Whitney U test, figure 1A). When jaundiced
patients were separated into groups with either benign
or malignant disease, a similar increase is seen in both
jaundiced groups.
There was no difference between plasma IL-12 lev-
els in thejaundiced and control groups (170.0+4.5 pg/
ml and 171.0+8.0 pg/ml respectively, p > 0.05, figure
1B). The differences between benign and malignant in
control or that in jaundiced are also not significant.
Monocyte IL-12 level in jaundiced patients had no
IL-12
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correlation with the plasma bilirubin, bile salt, or
aspartate aminotransferase.
DISCUSSION
This paper describes a previously unknown pheno-
menon, patients with biliary obstruction have a raised
monocyte interleukin- 12 production.
IL-12 is a recently identified cytokine which is pro-
duced by lymphocyte and monocyte/macrophage ce-
lls, It has major effects on lymphocyte and natural
killer (NK) cells (also known as NK cell stimulatory
factor, NKSF). This cytokine therefore has an impor-
tant role in natural and cellular immunity. It has been
reported recently that IL-12 may be in the future have
some promise as an agent in the treatment of certain
infections, such as leishmaniasis 2-2.
Obstructive jaundice is associated with increased
incidence of perioperative complications. It is also
established that these patients frequently suffer from
endotoxaemia 23-26. Both local and systemic endotoxa-
emia may therefore be responsible for the immune
malfunction injaundiced patients.
It is not clear by which pathway monocytes increase
their production in these patients. It has been reported
that IL-12 shares structural homology with IL-6, a
proinflammatory cytokines 27,28. IL-6 production from
’jaundiced’ monocyte is reported to be increased 29,30
and this increase may be due to endotoxaemia which
occurs in jaundiced patients. Increased IL-12 produc-
tion may. therefore share a similar pathway, this de-
serves further studies.
In summary, peripheral blood monocyte from ob-
structive jaundiced patients showed a greatly increa-
sed IL-12 production in both benign and malignant
aetiologies and this may contribute to the immune
malfunction in these patients.
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Figure 1 IL-12 levels in jaundiced patients assayed by ELISA. A:
produced by monocytes. B: plasma IL-12. There is a significant
increased production from monocytes.
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